bpc-157 rosacea bpc 157 We love a good before & after ✨, This patient came to us Flushing after wine, spicy foods,

Some have plausible mechanisms

Red Flags to Watch For Prescribers who skip baseline labs, offer peptides without a clinical evaluation, or guarantee specific outcomes should raise concern

Reduced inflammation in preclinical models has informed hypotheses for future clinical applications under controlled conditions

The positive effects may come with trade-offs we have not measured

Tirzepatide has a half-life of approximately 5 days (approximately 120 hours), which is the time required for half of the drug concentration to be eliminated from the bloodstream

Regulatory Status BPC 157 is not FDA-approved as a pharmaceutical drug